UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 720

Sortiert nach

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

Molecular cancer, 2016-11, Vol.15 (1), p.68-68, Article 68

2016

Link zum Volltext

Verfügbarkeit prüfen

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM

PloS one, 2012-03, Vol.7 (3), p.e33729

2012

Link zum Volltext

Verfügbarkeit prüfen

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

BMC cancer, 2019-10, Vol.19 (1), p.972-972, Article 972

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification and quantification of nuisance odors at a trash transfer station

Waste management (Elmsford), 2016-12, Vol.58, p.52-61

2016

Link zum Volltext

Verfügbarkeit prüfen

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

Molecular cancer, 2013-07, Vol.12 (1), p.85-85, Article 85

2013

Link zum Volltext

Verfügbarkeit prüfen

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

Scientific reports, 2023-11, Vol.13 (1), p.20634-20634, Article 20634

2023

Link zum Volltext

Verfügbarkeit prüfen

Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance

The Prostate, 2023-09, Vol.83 (12), p.1141-1149

2023

Link zum Volltext

Verfügbarkeit prüfen

Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol

BMJ open, 2022-02, Vol.12 (2), p.e056675-e056675

2022

Link zum Volltext

Verfügbarkeit prüfen

ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells

Clinical cancer research, 2015-06, Vol.21 (11), p.2569-2579

2015

Link zum Volltext

Verfügbarkeit prüfen

Prolonged disease control with MEK inhibitor in neurofibromatosis type I‐associated glioblastoma

Journal of clinical pharmacy and therapeutics, 2016-06, Vol.41 (3), p.357-359

2016

Link zum Volltext

Verfügbarkeit prüfen

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12

The Prostate, 2006-01, Vol.66 (1), p.32-48

2006

Link zum Volltext

Verfügbarkeit prüfen

Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells

Stem cells (Dayton, Ohio), 2008-06, Vol.26 (6), p.1425-1435

2008

Link zum Volltext

Verfügbarkeit prüfen

CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone

Molecular cancer research, 2008-03, Vol.6 (3), p.446-457

2008

Link zum Volltext

Verfügbarkeit prüfen

Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (13), p.5558-5566

2010

Link zum Volltext

Verfügbarkeit prüfen

Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial

Journal of clinical neuroscience, 2021-12, Vol.94, p.321-327

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of two standard odor intensity evaluation methods for odor problems in air or water

Water science and technology, 2014, Vol.69 (1), p.142

2014

Link zum Volltext

Verfügbarkeit prüfen

Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment

Seminars in cancer biology, 2005-04, Vol.15 (2), p.149-157

2005

Link zum Volltext

Verfügbarkeit prüfen

C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis

Neoplasia (New York, N.Y.), 2008-09, Vol.10 (9), p.996-1003

2008

Link zum Volltext

Verfügbarkeit prüfen

Maspin Expression Inhibits Osteolysis, Tumor Growth, and Angiogenesis in a Model of Prostate Cancer Bone Metastasis

Proceedings of the National Academy of Sciences - PNAS, 2003-06, Vol.100 (13), p.7847-7852

2003

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions

Molecular cancer research, 2013-11, Vol.11 (11), p.1349-1361

2013

Link zum Volltext

Verfügbarkeit prüfen

Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?

Current urology, 2021-06, Vol.15 (2), p.79-84

2021

Link zum Volltext

Verfügbarkeit prüfen

Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic

The Journal of urology, 2020-10, Vol.204 (4), p.720-725

2020

Link zum Volltext

Verfügbarkeit prüfen

New developments in primary CNS lymphoma

Journal of the neurological sciences, 2017-10, Vol.381, p.28-28

Cher, L.

2017

Link zum Volltext

Verfügbarkeit prüfen

A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth

Oncogene, 2012-10, Vol.31 (42), p.4527-4535

2012

Link zum Volltext

Verfügbarkeit prüfen

Matrix Metalloproteinase Activity, Bone Matrix Turnover, and Tumor Cell Proliferation in Prostate Cancer Bone Metastasis

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (1), p.17-25

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 720

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(617)
Mit Volltextzugriff
(609)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

Identification and quantification of nuisance odors at a trash transfer station

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance

Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol

ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells

Prolonged disease control with MEK inhibitor in neurofibromatosis type I‐associated glioblastoma

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12

Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells

CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone

Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration

Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial

Comparison of two standard odor intensity evaluation methods for odor problems in air or water

Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment

C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis

Maspin Expression Inhibits Osteolysis, Tumor Growth, and Angiogenesis in a Model of Prostate Cancer Bone Metastasis

Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions

Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?

Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic

New developments in primary CNS lymphoma

A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth

Matrix Metalloproteinase Activity, Bone Matrix Turnover, and Tumor Cell Proliferation in Prostate Cancer Bone Metastasis

Suchergebnisse filtern